Clinical Trials Browser

Phase 2 × Breast Neoplasms × tetrathiomolybdate × Clear all

NCT00195091 2025-05-16

Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer

Phase 2 Terminated

16 enrolled 5 charts

Breast Neoplasms

NCT00674557 2013-07-10

Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer

Phase 2 Terminated

Breast Neoplasms